Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Interim Management Statement

14 May 2010 08:51

RNS Number : 9274L
Computacenter PLC
14 May 2010
 



Interim Management Statement

 

14th May 2010

 

Computacenter plc, the independent IT services provider, is today holding its Annual General Meeting and publishes its Interim Management Statement based on unaudited financial information, for the period from 1 January 2010 to date.

 

Financial Performance

 

Group revenue, for the first quarter, increased by 7% to £634.4m on an as reported basis, which includes the effects of disposals, acquisitions and small currency movements. Excluding these effects, Group revenue for the first quarter increased by 8% to £616.0m and has seen similar growth rates in Q2 to date. Our Services revenue grew by 2% in Q1, and we have seen a small increase in this growth in Q2 to date. Group product revenue grew by 9% in Q1, including disposals, acquisitions and currency movements and by 12% excluding these effects and the growth has been maintained in Q2.

 

We have managed to achieve these growth rates with further reductions compared to Q1 2009, albeit small, to our cost base from last year's cost reduction program without exceptional costs. 

 

In the UK, we have seen a strong rebound in product sales, with growth of 20% excluding the disposal of CCD. This growth was flattered by one large project, which is not ongoing. However, excluding this project, the underlying growth rate was still greater than 10%, which has been maintained in Q2. UK services grew by 3% in Q1 and has increased further in Q2, due to new business gains.

 

As previously reported, we had a slow start to the year in Germany, but there was a material pick up in March. In the first quarter as a whole, product revenues grew 12% but only 1% if the acquisition of becom is excluded. Services declined by 3%, which was not materially affected by the acquisition. The improved trading in March has continued into Q2.

 

In France, the first quarter services revenue increased by 13% and product revenue by 7%. However, gross margins are lower than in Q1 2009, which was an artificially high position. Q2 to date has seen a similar trading performance to Q1. 

 

Financial Position

 

Despite the growth in our product business, our balance sheet continues to strengthen. At the end of Q1, net cash, excluding Customer Specific Financing (CSF), was approximately £89m (£86m at the end of Q4 2009). Net Funds including CSF was £53.3m (£37.3m at the end of Q4 2009). This position is still benefitting from an extended credit scheme with one of our major vendors, to the extent of approximately £30 million. There is no material change in this position since the end of Q1, despite the cash cost of paying the additional interim dividend totalling £11.8 million on 1 April 2010.

 

Outlook

 

After a challenging 2009 for our product business, we saw a strong rebound in Q1 2010, particularly in the UK. Whilst it is not certain that these growth rates can be maintained throughout the year, the signs are encouraging. Our services business has seen slower growth than we have become used to, but we are expecting this to improve as the year progresses. After a slow start to the year, our German business is showing some improvement. Trading this year to date across the Group has increased our confidence of another year of progress for Computacenter, in line with management expectations. 

 

Our next scheduled trading update will be the pre-close briefing prior to our Interim Results, which is scheduled for 13th July 2010.

 

Enquiries

 

Computacenter plc

 

Mike Norris, Chief Executive 01707 631601

 

Tony Conophy, Finance Director 01707 631515

 

Tessa Freeman, PR Manager 01707 631514

 

Tulchan Communications 020 7353 4200

 

Andrew Grant

 

Stephen Malthouse

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSSBRRSAVARR
Date   Source Headline
28th May 20267:00 amRNSAcquisition of Government Acquisitions Inc
19th May 20262:00 pmRNSResult of AGM
8th May 20262:00 pmRNSDirector/PDMR Shareholding
28th Apr 20261:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSQ1 Trading Update – 24 April 2026
8th Apr 202610:00 amRNS2025 Annual Financial Report & Notice of 2026 AGM
27th Mar 202610:00 amRNSDirector/PDMR Shareholding
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results 2025
5th Feb 20261:00 pmRNSBlock Listing Interim Review
22nd Jan 20267:00 amRNSPre-Close Trading Update – 22 January 2026
8th Jan 20267:00 amRNSAcquisition of AgreeYa Solutions Inc
6th Nov 20251:00 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSDirectorate Change
5th Aug 20251:00 pmRNSBlock listing Interim Review
31st Jul 20255:00 pmRNSHolding(s) in Company
31st Jul 20254:30 pmRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSTrading Update – 28 July 2025
26th Jun 20253:00 pmRNSDirector/PDMR Shareholding
15th May 20255:00 pmRNSResult of AGM
13th May 20255:45 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSQ1 Trading Update
9th Apr 20252:30 pmRNS2024 Annual Financial Report & Notice of 2025 AGM
2nd Apr 20252:30 pmRNSDirector/PDMR Shareholding
28th Mar 202510:00 amRNSDirector/PDMR Shareholding
26th Mar 20252:00 pmRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results 2024
6th Feb 202510:00 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNSPre-Close Trading Update
9th Jan 20257:00 amRNSDirectorate Change
16th Dec 20247:00 amRNSDirectorate Change
7th Nov 20245:00 pmRNSDirector/PDMR Shareholding
1st Nov 202412:00 pmRNSTotal Voting Rights
30th Oct 20246:14 pmRNSTransaction in Own Shares
30th Oct 20242:00 pmRNSDirector/PDMR Shareholding
29th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20247:00 amRNSQ3 Trading Update – 28 October 2024
25th Oct 20245:33 pmRNSTransaction in Own Shares
24th Oct 202412:00 pmRNSCancellation of Shares held in Treasury
24th Oct 20249:30 amRNSQ3 Trading Update - Release Date
23rd Oct 20245:49 pmRNSTransaction in Own Shares
22nd Oct 20246:18 pmRNSTransaction in Own Shares
18th Oct 20245:49 pmRNSTransaction in Own Shares
17th Oct 20245:48 pmRNSTransaction in Own Shares
16th Oct 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.